Purdue Autism Research Conference
October 18, 2018
Join researchers, students, and community members at the Purdue Autism Research Conference (PARC) to learn more about current research in diverse fields related to autism, ranging from basic to applied sciences. The daylong conference features keynote speakers Dr. Connie Kasari, an expert in social and communication interventions for children with autism, and Dr. David Amaral, an expert in biomedical and neural characteristics of auti
Autism and Inclusion: Building School Communities that Support All Learners (4/5/2018)
Thursday, April 5, 2018
Purdue University, Lawson Hall, rm 1142
Project DATA: Collaborating at school to meet the needs of young children with ASD (4/6/2018)
Friday, April 6, 2018
Beering Hall, rm 1248
Elizabeth M. Berry-Kravis, Thursday (10/6/2017) 4:00pm, MJIS 1001
Professor Elizabeth M. Berry-Kravis
Departments of Pediatrics, Neurology, and Biochemistry, Rush University Medical Center
Abstract: The talk will describe the clinical characteristics of fragile X syndrome, basic research and animal model work leading to understanding of the roles of FMRP in regulation of dendritic translation and synaptic morphology and plasticity, and aberrant regulation ensuing from absence of FMRP in FXS and FXS models. The development of treatments correcting the cellular translational pathway, synaptic functioning and numerous phenotypes in the animal models will be presented, followed by a discussion of the effort to bring these findings to humans with FXS, including hurdles, lessons learned, and resultant need to develop new paradigms for translation of treatments targeted to mechanisms of neural plasticity in neurodevelopmental disorders.
Elizabeth M. Berry-Kravis, MD, PhD is a professor of pediatrics, neurology, and biochemistry at Rush University Medical Center. She received a Bachelor's degree in chemistry from the University of Notre Dame in 1979, a PhD in biochemistry in 1983 and MD in 1985 from the University of Chicago. She completed a pediatrics residency in 1987 and pediatric neurology fellowship in 1990, also at the University of Chicago, and moved to Rush University Medical Center in 1992.
Dr. Berry-Kravis established the comprehensive Fragile X Clinic and Research Program at Rush in 1992, through which she provides care and support to over 400 patients with fragile X syndrome for management of neurological, medical, and behavioral and genetic issues. Her clinical research projects involve studies of epilepsy and psychopharmacology in fragile X, clinical trials of new promising medications in FXS and development of outcome measures and biomarkers for such trials in the FXS population. She is also involved in research to characterize neurological problems in fragile X-associated tremor/ataxia syndrome (FXTAS) and relate clinical and radiological findings to molecular measures in fragile X carriers. Her laboratory research involves studies of effects of fragile X mental retardation protein (FMRP) on signal transduction mechanisms in neural cells as well as molecular studies aimed at identifying genetic risks and genotype-phenotype relationships in neurological disorders, including Alzheimer’s disease, Parkinson’s disease, vascular dementia, congenital central hypoventilation syndrome and SIDS.
Robin Gabriels, Thursday (11/3/2017) 10:30-11:30am
Associate Professor Robin Gabriels
Departments of Psychiatry and Pediatrics, University of Colorado, Denver
Topics: Randomized clinical trial of therapeutic horseback riding for autism spectrum disorder (Project Number: 1R01NR012736-01) and ongoing human-animal interaction research in a specialty autism hospital unit
Robin Gabriels, Psy.D. is an Associate Professor (depts. of psychiatry and pediatrics at the University of Colorado Denver Anchutz Medical Campus and currently the PI on a 4-year project studying the Effects of Therapeutic Horseback Riding on Children and Adolescents with Autism (Project Number: 1R01NR012736-01). Dr. Gabriels is also the subcontract PI for a multi-site project funded by the Simons Foundation and Lurie Foundation with the aim to phenotype children with ASD admitted to autism specialty psychiatric hospital inpatient units. Dr. Gabriels established and is the Program Director of the Neuropsychiatric Special Care program, a psychiatric inpatient and day treatment unit for children with ASD and/or intellectual disabilities (ages 4 to 17) at Children’s Hospital Colorado. She has over 30 years of experience developing intervention programs along with assessing and treating a variety of pediatric and adult populations. Her clinical and research efforts have focused on the ASD population for the past 19 years. Dr. Gabriels is a certified Autism Diagnostic Observation Schedule trainer (including the ADOS-2) with the test authors, providing ADOS research reliability training for hospital and academic institutions across the United States. She has written many articles and book chapters on autism, and has lectured and conducted workshops on ASD, both nationally and internationally. She has published two edited books, Autism: From Research to Individualized Practice, (2002) Jessica Kingsley Publishers and Growing Up with Autism: Working with School-Age Children and Adolescents (2007) Guilford Press.